Loading…

Effects of chlordiazepoxide and FG 7142 on a rat model of diencephalic amnesia as measured by delayed-matching-to-sample performance

The intralaminar thalamic nuclei (ILn) have been implicated as a critical site of pathology in amnesia. Lesions of the ILn have been found to produce behavioral effects comparable to benzodiazepine (BDZ) receptor agonists. We compared the effects of chlordiazepoxide (CDP), a BDZ agonist, and FG 7142...

Full description

Saved in:
Bibliographic Details
Published in:Psychopharmacologia 1999-03, Vol.142 (4), p.413-420
Main Authors: BURK, J. A, GLODE, B. M, DRUGAN, R. C, MAIM, R. G
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c375t-e320983c1ea200f7ef5cefbcec057d271449056156ddbbdc6d013090db8f2b53
cites
container_end_page 420
container_issue 4
container_start_page 413
container_title Psychopharmacologia
container_volume 142
creator BURK, J. A
GLODE, B. M
DRUGAN, R. C
MAIM, R. G
description The intralaminar thalamic nuclei (ILn) have been implicated as a critical site of pathology in amnesia. Lesions of the ILn have been found to produce behavioral effects comparable to benzodiazepine (BDZ) receptor agonists. We compared the effects of chlordiazepoxide (CDP), a BDZ agonist, and FG 7142, a partial inverse agonist at the BDZ receptor, in rats with thalamic lesions and in unlesioned controls. Delayed matching-to sample (DMS) performances were studied during treatment with ascending doses of CDP, counterbalanced trials with 2.5 mg/kg CDP and saline, ascending doses of FG 7142, and (for unlesioned controls only) counterbalanced trials with saline and higher doses of CDP. CDP had effects similar to the ILn lesion, decreasing response speed and percent correct responding in a delay-independent fashion. These effects were additive with the impairments associated with the ILn lesion. The effects of FG 7142 were more complex. At lower doses, it increased response speed without affecting response accuracy. At higher doses, it diminished both the speed and the accuracy of DMS responding. These results support the hypothesis that ILn lesions and BDZ agonists have similar effects on DMS performance. The biphasic effects observed for FG 7142 are consistent with other evidence that low doses of this drug enhance while higher doses impair memory performance. Although DMS accuracy was not improved, the enhancement observed for response speed provides evidence that partial inverse BDZ agonists have potential utility as treatments for cognitive impairments associated with amnesia.
doi_str_mv 10.1007/s002130050907
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69729762</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17573986</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-e320983c1ea200f7ef5cefbcec057d271449056156ddbbdc6d013090db8f2b53</originalsourceid><addsrcrecordid>eNqF0U1r3DAQBmBRWppN2mOvRdDSm9qRZFv2sYQkLQR6yd2MpVHXwbJcyYZuzvnhVdiFflwqBLo8vGjmZeyNhI8SwHzKAEpqgBo6MM_YTlZaCQVGPWc7AK2FlnV7xs5zvodyqrZ6yc4kKNVBY3bs8cp7smvm0XO7n2JyIz7QEn-OjjjOjl_fcCMrxePMkSdceYiOpifuRpotLXucRssxzJRH5Jh5IMxbIseHAy8UD-REwNXux_m7WKPIGJaJ-ELJxxSwZLxiLzxOmV6f3gt2d311d_lF3H67-Xr5-VZYbepVkFbQtdpKQgXgDfnakh8sWaiNU-WbVQd1I-vGuWFwtnFQNtOBG1qvhlpfsA_H2CXFHxvltQ9jtjRNOFPcct90RnWmUf-F0tRGd21T4Lt_4H3c0lxm6LWUxjTlyqLEUdkUc07k-yWNAdOhl9A_ldj_VWLxb0-p2xDI_aGPrRXw_gQwW5x8Kksc829Xxmi01r8ASVmjJg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3117767761</pqid></control><display><type>article</type><title>Effects of chlordiazepoxide and FG 7142 on a rat model of diencephalic amnesia as measured by delayed-matching-to-sample performance</title><source>Springer Nature</source><source>SPORTDiscus with Full Text</source><creator>BURK, J. A ; GLODE, B. M ; DRUGAN, R. C ; MAIM, R. G</creator><creatorcontrib>BURK, J. A ; GLODE, B. M ; DRUGAN, R. C ; MAIM, R. G</creatorcontrib><description>The intralaminar thalamic nuclei (ILn) have been implicated as a critical site of pathology in amnesia. Lesions of the ILn have been found to produce behavioral effects comparable to benzodiazepine (BDZ) receptor agonists. We compared the effects of chlordiazepoxide (CDP), a BDZ agonist, and FG 7142, a partial inverse agonist at the BDZ receptor, in rats with thalamic lesions and in unlesioned controls. Delayed matching-to sample (DMS) performances were studied during treatment with ascending doses of CDP, counterbalanced trials with 2.5 mg/kg CDP and saline, ascending doses of FG 7142, and (for unlesioned controls only) counterbalanced trials with saline and higher doses of CDP. CDP had effects similar to the ILn lesion, decreasing response speed and percent correct responding in a delay-independent fashion. These effects were additive with the impairments associated with the ILn lesion. The effects of FG 7142 were more complex. At lower doses, it increased response speed without affecting response accuracy. At higher doses, it diminished both the speed and the accuracy of DMS responding. These results support the hypothesis that ILn lesions and BDZ agonists have similar effects on DMS performance. The biphasic effects observed for FG 7142 are consistent with other evidence that low doses of this drug enhance while higher doses impair memory performance. Although DMS accuracy was not improved, the enhancement observed for response speed provides evidence that partial inverse BDZ agonists have potential utility as treatments for cognitive impairments associated with amnesia.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/s002130050907</identifier><identifier>PMID: 10229067</identifier><identifier>CODEN: PSYPAG</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Accuracy ; Amnesia ; Amnesia - drug therapy ; Amnesia - psychology ; Animals ; Benzodiazepines ; Biological and medical sciences ; Carbolines - pharmacology ; Chlordiazepoxide ; Chlordiazepoxide - pharmacology ; Dose-Response Relationship, Drug ; Drug toxicity and drugs side effects treatment ; GABA-A Receptor Agonists ; Inverse agonists ; Lesions ; Male ; Matching-to-sample ; Medical sciences ; Memory - drug effects ; Pharmacology. Drug treatments ; Rats ; Thalamic nuclei ; Thalamic Nuclei - pathology ; Thalamus ; Toxicity: nervous system and muscle</subject><ispartof>Psychopharmacologia, 1999-03, Vol.142 (4), p.413-420</ispartof><rights>1999 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 1999.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-e320983c1ea200f7ef5cefbcec057d271449056156ddbbdc6d013090db8f2b53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1729633$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10229067$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BURK, J. A</creatorcontrib><creatorcontrib>GLODE, B. M</creatorcontrib><creatorcontrib>DRUGAN, R. C</creatorcontrib><creatorcontrib>MAIM, R. G</creatorcontrib><title>Effects of chlordiazepoxide and FG 7142 on a rat model of diencephalic amnesia as measured by delayed-matching-to-sample performance</title><title>Psychopharmacologia</title><addtitle>Psychopharmacology (Berl)</addtitle><description>The intralaminar thalamic nuclei (ILn) have been implicated as a critical site of pathology in amnesia. Lesions of the ILn have been found to produce behavioral effects comparable to benzodiazepine (BDZ) receptor agonists. We compared the effects of chlordiazepoxide (CDP), a BDZ agonist, and FG 7142, a partial inverse agonist at the BDZ receptor, in rats with thalamic lesions and in unlesioned controls. Delayed matching-to sample (DMS) performances were studied during treatment with ascending doses of CDP, counterbalanced trials with 2.5 mg/kg CDP and saline, ascending doses of FG 7142, and (for unlesioned controls only) counterbalanced trials with saline and higher doses of CDP. CDP had effects similar to the ILn lesion, decreasing response speed and percent correct responding in a delay-independent fashion. These effects were additive with the impairments associated with the ILn lesion. The effects of FG 7142 were more complex. At lower doses, it increased response speed without affecting response accuracy. At higher doses, it diminished both the speed and the accuracy of DMS responding. These results support the hypothesis that ILn lesions and BDZ agonists have similar effects on DMS performance. The biphasic effects observed for FG 7142 are consistent with other evidence that low doses of this drug enhance while higher doses impair memory performance. Although DMS accuracy was not improved, the enhancement observed for response speed provides evidence that partial inverse BDZ agonists have potential utility as treatments for cognitive impairments associated with amnesia.</description><subject>Accuracy</subject><subject>Amnesia</subject><subject>Amnesia - drug therapy</subject><subject>Amnesia - psychology</subject><subject>Animals</subject><subject>Benzodiazepines</subject><subject>Biological and medical sciences</subject><subject>Carbolines - pharmacology</subject><subject>Chlordiazepoxide</subject><subject>Chlordiazepoxide - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>GABA-A Receptor Agonists</subject><subject>Inverse agonists</subject><subject>Lesions</subject><subject>Male</subject><subject>Matching-to-sample</subject><subject>Medical sciences</subject><subject>Memory - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Thalamic nuclei</subject><subject>Thalamic Nuclei - pathology</subject><subject>Thalamus</subject><subject>Toxicity: nervous system and muscle</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqF0U1r3DAQBmBRWppN2mOvRdDSm9qRZFv2sYQkLQR6yd2MpVHXwbJcyYZuzvnhVdiFflwqBLo8vGjmZeyNhI8SwHzKAEpqgBo6MM_YTlZaCQVGPWc7AK2FlnV7xs5zvodyqrZ6yc4kKNVBY3bs8cp7smvm0XO7n2JyIz7QEn-OjjjOjl_fcCMrxePMkSdceYiOpifuRpotLXucRssxzJRH5Jh5IMxbIseHAy8UD-REwNXux_m7WKPIGJaJ-ELJxxSwZLxiLzxOmV6f3gt2d311d_lF3H67-Xr5-VZYbepVkFbQtdpKQgXgDfnakh8sWaiNU-WbVQd1I-vGuWFwtnFQNtOBG1qvhlpfsA_H2CXFHxvltQ9jtjRNOFPcct90RnWmUf-F0tRGd21T4Lt_4H3c0lxm6LWUxjTlyqLEUdkUc07k-yWNAdOhl9A_ldj_VWLxb0-p2xDI_aGPrRXw_gQwW5x8Kksc829Xxmi01r8ASVmjJg</recordid><startdate>19990301</startdate><enddate>19990301</enddate><creator>BURK, J. A</creator><creator>GLODE, B. M</creator><creator>DRUGAN, R. C</creator><creator>MAIM, R. G</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>19990301</creationdate><title>Effects of chlordiazepoxide and FG 7142 on a rat model of diencephalic amnesia as measured by delayed-matching-to-sample performance</title><author>BURK, J. A ; GLODE, B. M ; DRUGAN, R. C ; MAIM, R. G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-e320983c1ea200f7ef5cefbcec057d271449056156ddbbdc6d013090db8f2b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Accuracy</topic><topic>Amnesia</topic><topic>Amnesia - drug therapy</topic><topic>Amnesia - psychology</topic><topic>Animals</topic><topic>Benzodiazepines</topic><topic>Biological and medical sciences</topic><topic>Carbolines - pharmacology</topic><topic>Chlordiazepoxide</topic><topic>Chlordiazepoxide - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>GABA-A Receptor Agonists</topic><topic>Inverse agonists</topic><topic>Lesions</topic><topic>Male</topic><topic>Matching-to-sample</topic><topic>Medical sciences</topic><topic>Memory - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Thalamic nuclei</topic><topic>Thalamic Nuclei - pathology</topic><topic>Thalamus</topic><topic>Toxicity: nervous system and muscle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BURK, J. A</creatorcontrib><creatorcontrib>GLODE, B. M</creatorcontrib><creatorcontrib>DRUGAN, R. C</creatorcontrib><creatorcontrib>MAIM, R. G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Psychopharmacologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BURK, J. A</au><au>GLODE, B. M</au><au>DRUGAN, R. C</au><au>MAIM, R. G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of chlordiazepoxide and FG 7142 on a rat model of diencephalic amnesia as measured by delayed-matching-to-sample performance</atitle><jtitle>Psychopharmacologia</jtitle><addtitle>Psychopharmacology (Berl)</addtitle><date>1999-03-01</date><risdate>1999</risdate><volume>142</volume><issue>4</issue><spage>413</spage><epage>420</epage><pages>413-420</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><coden>PSYPAG</coden><abstract>The intralaminar thalamic nuclei (ILn) have been implicated as a critical site of pathology in amnesia. Lesions of the ILn have been found to produce behavioral effects comparable to benzodiazepine (BDZ) receptor agonists. We compared the effects of chlordiazepoxide (CDP), a BDZ agonist, and FG 7142, a partial inverse agonist at the BDZ receptor, in rats with thalamic lesions and in unlesioned controls. Delayed matching-to sample (DMS) performances were studied during treatment with ascending doses of CDP, counterbalanced trials with 2.5 mg/kg CDP and saline, ascending doses of FG 7142, and (for unlesioned controls only) counterbalanced trials with saline and higher doses of CDP. CDP had effects similar to the ILn lesion, decreasing response speed and percent correct responding in a delay-independent fashion. These effects were additive with the impairments associated with the ILn lesion. The effects of FG 7142 were more complex. At lower doses, it increased response speed without affecting response accuracy. At higher doses, it diminished both the speed and the accuracy of DMS responding. These results support the hypothesis that ILn lesions and BDZ agonists have similar effects on DMS performance. The biphasic effects observed for FG 7142 are consistent with other evidence that low doses of this drug enhance while higher doses impair memory performance. Although DMS accuracy was not improved, the enhancement observed for response speed provides evidence that partial inverse BDZ agonists have potential utility as treatments for cognitive impairments associated with amnesia.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>10229067</pmid><doi>10.1007/s002130050907</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0033-3158
ispartof Psychopharmacologia, 1999-03, Vol.142 (4), p.413-420
issn 0033-3158
1432-2072
language eng
recordid cdi_proquest_miscellaneous_69729762
source Springer Nature; SPORTDiscus with Full Text
subjects Accuracy
Amnesia
Amnesia - drug therapy
Amnesia - psychology
Animals
Benzodiazepines
Biological and medical sciences
Carbolines - pharmacology
Chlordiazepoxide
Chlordiazepoxide - pharmacology
Dose-Response Relationship, Drug
Drug toxicity and drugs side effects treatment
GABA-A Receptor Agonists
Inverse agonists
Lesions
Male
Matching-to-sample
Medical sciences
Memory - drug effects
Pharmacology. Drug treatments
Rats
Thalamic nuclei
Thalamic Nuclei - pathology
Thalamus
Toxicity: nervous system and muscle
title Effects of chlordiazepoxide and FG 7142 on a rat model of diencephalic amnesia as measured by delayed-matching-to-sample performance
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A51%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20chlordiazepoxide%20and%20FG%207142%20on%20a%20rat%20model%20of%20diencephalic%20amnesia%20as%20measured%20by%20delayed-matching-to-sample%20performance&rft.jtitle=Psychopharmacologia&rft.au=BURK,%20J.%20A&rft.date=1999-03-01&rft.volume=142&rft.issue=4&rft.spage=413&rft.epage=420&rft.pages=413-420&rft.issn=0033-3158&rft.eissn=1432-2072&rft.coden=PSYPAG&rft_id=info:doi/10.1007/s002130050907&rft_dat=%3Cproquest_cross%3E17573986%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-e320983c1ea200f7ef5cefbcec057d271449056156ddbbdc6d013090db8f2b53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3117767761&rft_id=info:pmid/10229067&rfr_iscdi=true